These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Amantadine in the therapy of Parkinson syndromes]. Pfaff G Med Klin; 1980 Oct; 75(22):792-4. PubMed ID: 7453628 [No Abstract] [Full Text] [Related]
11. Amantadine for levodopa resistant parkinsonism. Sandyk R; Iacono RP; Snider SR Int J Neurosci; 1987 Feb; 32(3-4):715-7. PubMed ID: 3596918 [TBL] [Abstract][Full Text] [Related]
12. [Apomorphine test: evaluation of dopaminergic response in patients with Parkinson disease]. Miranda M; Saéz D Rev Med Chil; 1995 Mar; 123(3):326-9. PubMed ID: 8525172 [TBL] [Abstract][Full Text] [Related]
13. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center]. Antonini FM; Baroni A Minerva Med; 1971 Oct; 62(82):4027-30. PubMed ID: 5125072 [No Abstract] [Full Text] [Related]
15. The treatment of parkinsonism with L-Dopa and amantadine. Green J J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813 [No Abstract] [Full Text] [Related]
16. [Therapeutic effects of amantadine hydrochloride on manifestations of parkinsonism]. Espadaler Medina JM; Olivella Rius J; Ruscadella Nadal J Rev Esp Otoneurooftalmol Neurocir; 1969-1970; 28(164):236-46. PubMed ID: 5398580 [No Abstract] [Full Text] [Related]
17. Early idiopathic parkinsonism: initiation and optimization of treatment. Calne DB Clin Neuropharmacol; 1994; 17 Suppl 2():S14-8. PubMed ID: 9358191 [TBL] [Abstract][Full Text] [Related]
18. Personal experience with a combination of drugs in subjects with dopa resistant Parkinson's disease. Mastrosimone F; Colucci d'Amato C; De Angelis G; Iaccarino C; Giordano L; Marmo E J Med; 1980; 11(5-6):377-83. PubMed ID: 6962824 [No Abstract] [Full Text] [Related]
19. [Current treatment of Parkinsonism with amantadine hydrochloride]. Gerstenbrand F; Gründig E; Musiol A Pol Tyg Lek; 1972 Jul; 27(23):878-9. PubMed ID: 5040531 [No Abstract] [Full Text] [Related]
20. [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient]. Ceballos-Baumann AO MMW Fortschr Med; 2002 May; Suppl 2():37-43. PubMed ID: 12070848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]